Maple Rock Capital Partners’s Ingevity NGVT Stock Holding History
Bought
Maintained
Sold
Other funds holding NGVT
VPM
VCM
SBH
SCM
Maple Rock Capital Partners's NGVT Position: Q1 2026 in Review
Maple Rock Capital Partners reduced its Ingevity (NGVT) stake by 11% in Q1 2026, selling an estimated $4.88M and leaving 603,303 shares worth $43M. The position accounts for 1.4% of the portfolio, ranked #24.
Maple Rock Capital Partners first reported a position in NGVT in Q2 2016 and has held it in 24 quarters since. The position peaked at $59.6M in Q2 2022. 307 funds tracked by Wall St. Rank hold NGVT as of Q1 2026.
- Maple Rock Capital Partners held 603,303 shares of Ingevity worth $43M as of Q1 2026.
- Maple Rock Capital Partners sold 71,413 Ingevity shares in Q1 2026, an estimated $4.88M.
- Ingevity made up 1.4% of Maple Rock Capital Partners's portfolio in Q1 2026, its #24 holding.
- Maple Rock Capital Partners first reported a position in Ingevity in Q2 2016 and has held it in 24 quarters since.
- Maple Rock Capital Partners's Ingevity position peaked at $59.6M in Q2 2022.
- 307 funds tracked by Wall St. Rank held Ingevity as of Q1 2026.
Based on Maple Rock Capital Partners's 13F filing for Q1 2026, filed 15 May 2026.